Drug Manufacturers - Specialty & Generic Companies By Pe Ratio

Price To Earning
Price To EarningEfficiencyMarket RiskExp Return
1LNTH Lantheus Holdings
36.43
(0.05)
 3.64 
(0.19)
2SXTC China SXT Pharmaceuticals
5.73
(0.08)
 6.36 
(0.51)
3YCBD-PA cbdMD Inc
0.0
 0.12 
 4.94 
 0.60 
4NSRS North Springs Resources
0.0
 0.00 
 0.00 
 0.00 
5695156AW9 PKG 305 01 OCT 51
0.0
(0.05)
 0.96 
(0.05)
6695156AV1 US695156AV10
0.0
(0.01)
 1.09 
(0.01)
7695156AU3 US695156AU37
0.0
(0.16)
 0.72 
(0.11)
8695156AT6 PACKAGING P AMER
0.0
(0.10)
 0.38 
(0.04)
9HROWM Harrow Health, 11875
0.0
 0.10 
 0.49 
 0.05 
10GELS Gelteq Limited Ordinary
0.0
(0.13)
 8.80 
(1.18)
11695114CG1 PACIFICORP 625 percent
0.0
(0.05)
 0.97 
(0.05)
12695114CD8 PACIFICORP 575 percent
0.0
 0.05 
 1.27 
 0.06 
13695114CL0 PACIFICORP 6 percent
0.0
 0.04 
 1.47 
 0.06 
14695114CJ5 PACIFICORP 635 percent
0.0
(0.10)
 1.99 
(0.19)
15695114CN6 PACIFICORP 41 percent
0.0
(0.03)
 1.38 
(0.05)
16695114BZ0 US695114BZ08
0.0
(0.09)
 1.46 
(0.14)
17695114BX5 US695114BX59
0.0
 0.03 
 2.50 
 0.08 
18695114CX4 US695114CX41
0.0
 0.10 
 1.71 
 0.17 
19695114CZ9 BRKHEC 535 01 DEC 53
0.0
(0.07)
 1.76 
(0.12)
20695114CY2 PACIFICORP
0.0
(0.12)
 1.96 
(0.23)
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit. Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.